This National Ebola Training and Education Center course discusses the assessment, management, and placement of persons suspected to have Ebola and Other Special Pathogens.
.This course facilitates learners to describe pathogen-related factors that may warrant treatment in a biocontainment unit and to distinguish between concepts of infectious, communicable, and hazardous as they relate to Ebola and other special pathogens of concern. Participants will also be able to describe the clinical presentation of selected special pathogens from the two broad categories: viral hemorrhagic fevers and the highly pathogenic respiratory viruses.
This resource provides links to legislation and regulations related to medical countermeasures.
This video is a recording of the meeting of the Blue Ribbon Study Panel on Biodefense. It covers:
- Current transnational biological threats;
- Homeland defense and security in the global context;
- Global security efforts to combat these threats;
- International public health security efforts; and
- The need to elevate global health security as a national and global priority.
This video offers program leaders from within the US Centers for Disease Control and Prevention (CDC), US Department of Defense (DoD), and US Agency for International Development (USAID) speak to their work in reducing biological threats globally.
The Pandemic Response Box contains 400 diverse drug-like molecules active against bacteria, viruses or fungi.
This factsheet provides the latest information on African swine fever.
This document is intended to help organizations who want to provide care for Ebola virus disease/viral hemorrhagic fever patients determine an appropriate level of medical care that they can provide and anticipate the supplies that may be needed.
This template is designed to assist laboratories in the development of their risk assessment for Ebola Virus Disease. It may not be comprehensive as each facility will have their laboratory specific risk assessment procedures.